Oramed Pharmaceuticals EBITDA 2011-2024 | ORMP
Oramed Pharmaceuticals ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Oramed Pharmaceuticals Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-13 |
| 2023 | $-16 |
| 2022 | $-41 |
| 2021 | $-12 |
| 2021 | $-24 |
| 2020 | $-12 |
| 2019 | $-15 |
| 2018 | $-14 |
| 2017 | $-11 |
| 2016 | $-10 |
| 2015 | $-7 |
| 2014 | $-6 |
| 2013 | $-4 |
| 2012 | $0 |
| 2012 | $-3 |
| 2011 | $-1 |
| 2011 | $-2 |
| 2010 | $-1 |
| Oramed Pharmaceuticals Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-4 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-5 |
| 2022-12-31 | $-10 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-11 |
| 2021-12-31 | $8 |
| 2021-11-30 | $-8 |
| 2021-09-30 | $-7 |
| 2021-08-31 | |
| 2021-06-30 | $-4 |
| 2021-05-31 | $-6 |
| 2021-03-31 | $-7 |
| 2021-02-28 | $-5 |
| 2020-11-30 | $-6 |
| 2020-08-31 | |
| 2020-05-31 | $-2 |
| 2020-02-29 | $-4 |
| 2019-11-30 | $-2 |
| 2019-08-31 | |
| 2019-05-31 | $-4 |
| 2019-02-28 | $-4 |
| 2018-11-30 | $-5 |
| 2018-08-31 | |
| 2018-05-31 | $-5 |
| 2018-02-28 | $-3 |
| 2017-11-30 | $-3 |
| 2017-08-31 | |
| 2017-05-31 | $-2 |
| 2017-02-28 | $-3 |
| 2016-11-30 | $-2 |
| 2016-08-31 | |
| 2016-05-31 | $-2 |
| 2016-02-29 | $-2 |
| 2015-11-30 | $-2 |
| 2015-08-31 | |
| 2015-05-31 | $-2 |
| 2015-02-28 | $-2 |
| 2014-11-30 | $-2 |
| 2014-08-31 | |
| 2014-05-31 | $-2 |
| 2014-02-28 | $-1 |
| 2013-11-30 | $-1 |
| 2013-08-31 | |
| 2013-05-31 | $-1 |
| 2013-02-28 | $-1 |
| 2012-12-31 | |
| 2012-11-30 | $-1 |
| 2012-08-31 | |
| 2012-05-31 | $-1 |
| 2012-02-29 | $-1 |
| 2011-11-30 | $0 |
| 2011-09-30 | |
| 2011-08-31 | |
| 2011-06-30 | $0 |
| 2011-05-31 | $-1 |
| 2011-03-31 | $0 |
| 2011-02-28 | $-1 |
| 2010-12-31 | $-1 |
| 2010-11-30 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.093B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||